Nomura Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.8M Sell
93,225
-1,053
-1% -$358K 0.08% 250
2025
Q4
$37.5M Buy
94,278
+4,409
+5% +$1.95M 0.09% 221
2025
Q3
$41M Sell
89,869
-1,505
-2% -$613K 0.11% 203
2025
Q2
$29.8M Buy
91,374
+4,531
+5% +$1.25M 0.08% 257
2025
Q1
$23.4M Buy
86,843
+4,058
+5% +$1.04M 0.07% 265
2024
Q4
$19.5M Sell
82,785
-2,660
-3% -$700K 0.06% 286
2024
Q3
$23.5M Buy
85,445
+6,148
+8% +$1.6M 0.07% 249
2024
Q2
$19.3M Sell
79,297
-446
-0.6% -$70.4K 0.07% 257
2024
Q1
$11.9M Buy
79,743
+10,732
+16% +$1.79M 0.04% 345
2023
Q4
$13.2M Buy
69,011
+994
+1% +$169K 0.05% 314
2023
Q3
$12M Buy
68,017
+1,804
+3% +$344K 0.06% 307
2023
Q2
$12.6M Sell
66,213
-1,085
-2% -$215K 0.06% 301
2023
Q1
$13.5M Buy
67,298
+9,798
+17% +$2.06M 0.07% 278
2022
Q4
$13.7M Sell
57,500
-1,308
-2% -$279K 0.08% 269
2022
Q3
$11.8M Sell
58,808
-2,176
-4% -$415K 0.07% 279
2022
Q2
$8.89M Sell
60,984
-1,926
-3% -$273K 0.06% 323
2022
Q1
$10.3M Sell
62,910
-617
-1% -$94K 0.06% 328
2021
Q4
$10.8M Buy
63,527
+20,703
+48% +$3.85M 0.05% 316
2021
Q3
$8.09M Buy
42,824
+1,015
+2% +$190K 0.05% 351
2021
Q2
$7.09M Buy
41,809
+1,195
+3% +$175K 0.04% 390
2021
Q1
$5.73M Buy
40,614
+20,099
+98% +$3.02M 0.04% 420
2020
Q4
$2.67M Buy
20,515
+1,420
+7% +$190K 0.02% 605
2020
Q3
$2.78M Hold
19,095
0.02% 512
2020
Q2
$2.83M Buy
19,095
+505
+3% +$68.1K 0.02% 482
2020
Q1
$2.02M Buy
18,590
+1,000
+6% +$115K 0.02% 504
2019
Q4
$2.03M Sell
17,590
-510
-3% -$50.8K 0.02% 616
2019
Q3
$1.46M Buy
18,100
+4,560
+34% +$361K 0.01% 681
2019
Q2
$982K Hold
13,540
0.01% 781
2019
Q1
$1.26M Hold
13,540
0.01% 703
2018
Q4
$987K Buy
13,540
+1,600
+13% +$123K 0.01% 702
2018
Q3
$1.04M Hold
11,940
0.01% 728
2018
Q2
$1.18M Buy
11,940
+1,200
+11% +$119K 0.01% 700
2018
Q1
$1.28M Hold
10,740
0.01% 662
2017
Q4
$1.36M Buy
+10,740
New +$1.35M 0.02% 641
2017
Q3
Hold
0
924
2017
Q2
Hold
0
946
2017
Q1
Hold
0
974
2016
Q4
Sell
-8,000
Closed -$335K 1441
2016
Q3
$542K Hold
8,000
0.01% 798
2016
Q2
$444K Hold
8,000
0.01% 813
2016
Q1
$502K Buy
8,000
+500
+7% +$33.2K 0.01% 791
2015
Q4
$706K Hold
7,500
0.01% 721
2015
Q3
$603K Buy
7,500
+200
+3% +$22.2K 0.01% 760
2015
Q2
$875K Buy
+7,300
New +$872K 0.02% 653

Other funds holding ALNY